Glaxosmithkline Plc
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 6 superinvestors own shares of Glaxosmithkline Plc (GLAXF), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Glaxosmithkline Plc (GLAXF), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Glaxosmithkline Plc (GLAXF) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Glaxosmithkline Plc (GLAXF) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
Superinvestor | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
Irving Kahn / Thomas G. Kahn@Kahn Brothers Group Inc
| 7.46% | $43.285M 1.059M shares@ 40.89 avg price | Decreased -14.69% |
Javier Alvarez@Eagle Asset Management Inc
| 0.01% | $675,356 18,610 shares@ 36.29 avg price | Increased 11.3% |
Jessica Hoard@Columbia Asset Management
| 0.07% | $373,000 9,130 shares@ 40.86 avg price | Increased 0.06% |
James E. Francis@Paradigm Asset Management Co Llc
| 0.02% | $61,320 1,500 shares@ 40.88 avg price | Decreased -16.66% |
Thomas J. Karwacki@Park Circle Co
| 0.03% | $32,704 800 shares@ 40.88 avg price | |
Robert Major@Huntington National Bank
| 0.01% | $40 1 shares@ 40.0 avg price |